HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A ten year study of heparin therapy for thrombophlebitis in ambulatory patients.

Abstract
During the past ten years, we have observed 407 patients with thrombophlebitis using a standardized outpatient regimen including subcutaneously self-administered heparin therapy. A definite protocol for tapering and discontinuing anticoagulants was applied which allows a correlation between duration of heparin administration, decreasing heparin resistance and symptomatic improvement. In acute and subacute thrombophlebitis, this method induced symptomatic resolution within less than two months in half of the patients and within less than six months in 78%. The number of recurrences during the follow-up period was acceptable and the frequency of complications minimal. We conclude that, except in the most severe, toxic instances of thrombophlebitis or in suspected pulmonary embolism, hospitalization--complete bedrest and intravenously administered anticoagulants--is unnecessary and wasteful.
AuthorsR M Stillman, L Chapa, M L Stark, L N Malik, J R Keates, P N Sawyer
JournalSurgery, gynecology & obstetrics (Surg Gynecol Obstet) Vol. 145 Issue 2 Pg. 193-7 (Aug 1977) ISSN: 0039-6087 [Print] United States
PMID877837 (Publication Type: Journal Article)
Chemical References
  • Heparin
  • Aspirin
Topics
  • Acute Disease
  • Adolescent
  • Adult
  • Aged
  • Ambulatory Care
  • Aspirin (therapeutic use)
  • Blood Coagulation Tests
  • Chronic Disease
  • Female
  • Heparin (therapeutic use)
  • Humans
  • Male
  • Middle Aged
  • Syndrome
  • Thrombophlebitis (complications, diagnosis, drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: